[go: up one dir, main page]

NO920983D0 - PROCEDURE FOR THE TREATMENT OF NEVRODEGENERATIVE CONDITIONS - Google Patents

PROCEDURE FOR THE TREATMENT OF NEVRODEGENERATIVE CONDITIONS

Info

Publication number
NO920983D0
NO920983D0 NO1992920983A NO920983A NO920983D0 NO 920983 D0 NO920983 D0 NO 920983D0 NO 1992920983 A NO1992920983 A NO 1992920983A NO 920983 A NO920983 A NO 920983A NO 920983 D0 NO920983 D0 NO 920983D0
Authority
NO
Norway
Prior art keywords
nevrodegenerative
procedure
treatment
conditions
nevrodegenerative conditions
Prior art date
Application number
NO1992920983A
Other languages
Norwegian (no)
Other versions
NO920983L (en
Inventor
Paul Jerome Marangos
Harry Edward Gruber
Original Assignee
Gensia Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gensia Pharma filed Critical Gensia Pharma
Publication of NO920983L publication Critical patent/NO920983L/en
Publication of NO920983D0 publication Critical patent/NO920983D0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Treatment Of Fiber Materials (AREA)
NO1992920983A 1989-09-15 1992-03-13 PROCEDURE FOR THE TREATMENT OF NEVRODEGENERATIVE CONDITIONS NO920983D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40791389A 1989-09-15 1989-09-15
PCT/US1990/005180 WO1991004032A1 (en) 1989-09-15 1990-09-12 Methods of treating neurodegenerative conditions

Publications (2)

Publication Number Publication Date
NO920983L NO920983L (en) 1992-03-13
NO920983D0 true NO920983D0 (en) 1992-03-13

Family

ID=23614067

Family Applications (1)

Application Number Title Priority Date Filing Date
NO1992920983A NO920983D0 (en) 1989-09-15 1992-03-13 PROCEDURE FOR THE TREATMENT OF NEVRODEGENERATIVE CONDITIONS

Country Status (6)

Country Link
EP (1) EP0491792A4 (en)
JP (1) JPH05506842A (en)
KR (1) KR920703068A (en)
AU (1) AU643235B2 (en)
NO (1) NO920983D0 (en)
WO (1) WO1991004032A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993003148A2 (en) * 1991-08-09 1993-02-18 Massachusetts Institute Of Technology Tau/neurofilament protein kinases pk40 and pk36
DK62592D0 (en) * 1992-05-14 1992-05-14 Novo Nordisk As
CA2101311A1 (en) * 1992-07-31 1994-02-01 Neelakantan Balasubramanian Adenosine re-uptake inhibiting derivatives of diphenyl oxazoles, thiazoles and imidazoles
US5589467A (en) * 1993-09-17 1996-12-31 Novo Nordisk A/S 2,5',N6-trisubstituted adenosine derivatives
US5780450A (en) * 1995-11-21 1998-07-14 Alcon Laboratories, Inc. Use of adenosine uptake inhibitors for treating retinal or optic nerve head damage
DE19707655A1 (en) * 1997-02-26 1998-08-27 Hoechst Ag Combination preparation for use in dementia
US6440455B1 (en) * 1997-09-02 2002-08-27 Children's Medical Center Corporation Methods for modulating the axonal outgrowth of central nervous system neurons

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4575498A (en) * 1983-07-21 1986-03-11 Duke University Method for restoring depleted purine nucleotide pools
US4912092A (en) * 1986-03-27 1990-03-27 The Regents Of The University Of California Methods for increasing extracellular adenosine and for stabilizing mast cells

Also Published As

Publication number Publication date
EP0491792A4 (en) 1992-12-02
WO1991004032A1 (en) 1991-04-04
AU6401590A (en) 1991-04-18
KR920703068A (en) 1992-12-17
JPH05506842A (en) 1993-10-07
NO920983L (en) 1992-03-13
AU643235B2 (en) 1993-11-11
EP0491792A1 (en) 1992-07-01

Similar Documents

Publication Publication Date Title
NO934304L (en) Procedure for the treatment of fluoroalumosilicate glass
NO173498C (en) Analogous procedure for the preparation of substituted 9-amino-tetrahydroacridines
NO902003D0 (en) PROCEDURE FOR THE PREPARATION OF N-HETEROARYL-4-QUINOLINAMINES.
NO901554D0 (en) PROCEDURE FOR THE PREPARATION OF DINATE-CEFODIZIM.
NO921962D0 (en) PROCEDURE FOR THE PREPARATION OF SULFAT PREPARATION
NO171974C (en) PROCEDURE FOR THE MANUFACTURING OF NIGHT-MAINTENANCE DERIVATIVES
NO930574L (en) Procedure for the preparation of desfluran
NO921993D0 (en) PROCEDURE FOR THE TREATMENT OF AMPOTAIR OR SWITTERIONIC TENSIDES
FI890185A7 (en) Process for the preparation of 1-alkyl-5-nitroimidazoles
NO920983L (en) PROCEDURE FOR THE TREATMENT OF NEVRODEGENERATIVE CONDITIONS
NO913117L (en) PROCEDURE FOR THE TREATMENT OF NECESSARY DISEASES.
NO893890L (en) PROCEDURE FOR THE REMOVAL OF SULPHIDS.
NO900969L (en) PROCEDURE FOR THE PREPARATION OF N-ALLYMETATE TRIFLUORMETHYLANILINE.
NO901067L (en) PROCEDURE FOR THE PREPARATION OF TIOPHENES.
NO171373C (en) PROCEDURE FOR THE MANUFACTURE OF BISCAR BAMBATES
FI902590A7 (en) Process for the preparation of 2-oxoindole-1-carboxamides
NO901422L (en) PROCEDURE FOR THE PREPARATION OF ALFA-GLUCOSIDASE INHIBITORS.
NO884635D0 (en) PROCEDURE FOR TREATMENT OF MUST.
KR890701106A (en) Use of oxoquinazoline derivatives for the treatment of hyperlipidemia
NO920694D0 (en) PROCEDURE FOR TREATMENT OF TREMASS
NO171565C (en) PROCEDURE FOR TREATMENT OF MANGANSLAM
NO904070D0 (en) PROCEDURE FOR THE PREPARATION OF ALKANPHENONES.
NO902968D0 (en) PROCEDURE FOR TREATMENT OF BORESLAM.
NO930481L (en) PROCEDURE FOR THE PREPARATION OF CHLORMETHANE
FI904950A7 (en) Process for the preparation of 3-alkoxy-4-hydroxybenzaldehydes